Pharma cos promote Indian generics in global market

A A

BV Mahalakshmi: Hyderabad, Dec 19 2012, 03:55 IST

The Indian pharmaceutical industry, currently valued at $22 billion and ranked third in terms of volume and 13th in terms of value globally, is on a brand promotion drive called ‘Rx India’. The goal is to promote confidence among the buyers in the global market and tap the generic opportunity in both regulated and non-regulated markets.

The brand promotion has been taken up by the India Brand Equity Foundation (IBEF) and Pharmaceuticals Export Promotion Council of India (Pharmexil) carrying a a tagline ‘Pharmacy of the world’ to market the domestic industry globally.

Speaking to FE, PV Appaji, director general, Pharmaceuticals Export Promotion Council of India (Pharmexcil), said, “We are working together to promote the Rx India label in the global markets which would include both regulated and non-regulated markets,” he said.

“The Indian pharma exports, which is currently at $13.4 billion, is expected to reach $25 billion by 2015,’’ he said. It grew by 23.34% in the last fiscal. Incidentally, the total exports during the last five years grew by 16% CAGR.

While dismissing the recent incidents on the nature of Indian drugs as spurious or sub-standard, he said that the quality of drugs exported from the country adheres to the international guidelines as stipulated by country-specific regulations.

Besides, there is also a proposal by the ministry to empower the state drug departments to monitor movement of the products.

“Our purpose is to develop confidence in buyers that India is a dependable source for generic formulations and promises quality and affordable prices on a sustained basis,”

... contd.

Ads by Google

Single Page Format

1 | 2 | Next